Search Results - "Bitossi, R"

Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy by Tampellini, M, Polverari, R S, Ottone, A, Alabiso, I, Baratelli, C, Bitossi, R, Brizzi, M P, Leone, F, Forti, L, Bertona, E, Racca, P, Mecca, C, Alabiso, O, Aglietta, M, Berruti, A, Scagliotti, G V

“…Seasonal variation of baseline diagnosis (or clinical suspect) of stage I-III colorectal cancer patients has been repeatedly reported as an independent…”
Get more information

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients by TAMPELLINI, M, SAINI, A, MIRAGLIA, S, FORTI, L, ALABISO, O, AGLIETTA, M, HARRIS, A, DOGLIOTTI, L, ALABISO, I, BITOSSI, R, BRIZZI, M. P, SCULLI, C. M, BERRUTI, A, GORZEGNO, G, MAGNINO, A, SPERTI, E

“…The purpose of the study was to evaluate the influence of baseline haemoglobin level in predicting response to 5-fluorouracil (5FU)-based first-line…”
Get full text

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines by BERRUTI, A, BITOSSI, R, ARDINE, M, BERTETTO, O, DANESE, S, SAROBBA, M. G, FARRIS, A, LORUSSO, V, DOGLIOTTI, L, GORZEGNO, G, BOTTINI, A, GENERALI, D, MILANI, M, KATSAROS, D, RIGAULT DE LA LONGRAIS, I. A, BELLINO, R, DONADIO, M

“…We investigated the activity and toxicity of a combination of vinorelbine (VNB), paclitaxel (PTX) and 5-fluorouracil (5-FU) continuous infusion administered as…”
Get full text

Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse by Tampellini, M, Berruti, A, Gorzegno, G, Bitossi, R, Bottini, A, Durando, A, De Matteis, A, Farris, A, Donadio, M, De Fabiani, E, Manzin, E, Arese, P, Sarobba, M G, Castiglione, F, Moro, G, Bonazzi, G, Nuzzo, F, Massobrio, M, Dogliotti, L

“…Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis, staging or surveillance of breast cancer patients…”
Get more information

Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy by Tampellini, M., Ottone, A., Alabiso, I., Baratelli, C., Bitossi, R., Brizzi, M.P., Leone, F., Forti, L., Bertona, E., Racca, P., Mecca, C., Alabiso, O., Aglietta, M., Berruti, A., Scagliotti, G.V.

Get full text

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline by Berruti, A, Dogliotti, L, Bitossi, R, Fasolis, G, Gorzegno, G, Bellina, M, Torta, M, Porpiglia, F, Fontana, D, Angeli, A

“…We evaluated the incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease. We also assessed the…”
Get more information

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation by Saini, Andrea, Berruti, Alfredo, Sperone, Paola, Bitossi, Raffaella, Tampellini, Marco, Dogliotti, Luigi, Gorzegno, Gabriella

Get more information

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design by BERRUTI, Alfredo, BITOSSI, Raffaella, LORUSSO, Vito, FARRIS, Antonio, SAROBBA, Maria Giuseppa, DEFABIANI, Enza, BONAZZI, Giorgio, CASTIGLIONE, Federico, BUMMA, Cesare, MORO, Gregorio, BRUZZI, Paolo, DOGLIOTTI, Luigi, GORZEGNO, Gabriella, BOTTINI, Alberto, ALQUATI, Palmiro, DE MATTEIS, Andrea, NUZZO, Francesco, GIARDINA, Giorgio, DANESE, Saverio, DE LENA, Mario

“…To investigate the value of the addition of either cisplatin (CDDP) or lonidamine (LND) to epirubicin (EPI) in the first-line treatment of advanced breast…”
Get full text

TGFalfa, EGFR and p70S6K expression in aggressive colorectal cancer (CRC) by Tampellini, M., Longo, M., Cappia, S., Bacillo, E., Brizzi, M., Bitossi, R., Sculli, C. M., Alabiso, I., Dogliotti, L., Papotti, M.

“…Abstract only 13505 Background: Autocrine TGFa in CRC cells regulates cell adhesion via p70S6K phosphorylation in in vitro studies. The aim was to evaluate…”
Get full text

Predictive factors for skeletal complications in prostate cancer patients with hormone refractory disease by Tucci, M., Berruti, A., Mosca, A., Vana, F., La Manna, G., Russo, L., Poggio, M., Bitossi, R., Gorzegno, G., Tampellini, M., Saini, A.

“…Abstract only…”
Get full text

The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients by Tampellini, M., Saini, A., Alabiso, I., Bitossi, R., Brizzi, M. P., Berruti, A., Gorzegno, G., Miraglia, S., Alabiso, O., Dogliotti, L.

“…Abstract only…”
Get full text

Prognostic role of plasma chromogranin A levels in prostate cancer patients with hormone refractory disease by Mosca, A., Berruti, A., Tucci, M., Vana, F., Bitossi, R., Cracco, C., Torta, M., Poggio, M., Scarpa, R. M., Dogliotti, L.

“…Abstract only…”
Get full text

Prognostic role of plasma chromogranin A levels in prostate cancer patients with hormone refractory disease by Mosca, A., Berruti, A., Tucci, M., Vana, F., Bitossi, R., Cracco, C., Torta, M., Poggio, M., Scarpa, R. M., Dogliotti, L.

“…Abstract only…”
Get full text

The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients by Tampellini, M., Saini, A., Alabiso, I., Bitossi, R., Brizzi, M. P., Berruti, A., Gorzegno, G., Miraglia, S., Alabiso, O., Dogliotti, L.

“…Abstract only…”
Get full text

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naïve metastatic breast cancer patients by Berruti, Alfredo, Bitossi, Raffaella, Bottini, Alberto, Bonardi, Simone, Donadio, Michela, Nigro, Cinzia, Bertetto, Oscar, Danese, Saverio, Bertone, Elena, Sarobba, Maria Giuseppa, Farris, Antonio, Katsaros, Dionyssios, Castiglione, Federico, Volpe, Teresa, Lattuada, Sara, Mancarella, Sergio, Dogliotti, Luigi

“…We investigated the activity and toxicity of a combination of vinorelbine 25 mg/m 2 on days 1 and 15; epirubicin 25 mg/m 2 on days 1, 8, 15; and 5-fluorouracil…”
Get full text

Feasibility of 21-day Continuous Infusion of Epirubicin in Hormone-refractory Prostate Cancer Patients by BERRUTI, Alfredo, MOSCA, Alessandra, DOGLIOTTI, Luigi, BITOSSI, Raffaella, GORZEGNO, Gabriella, GUERCIO, Stefano, POGGIO, Massimiliano, TAMPELLINI, Marco, PORPIGLIA, Francesco, OSTELLINO, Oliviero, SCARPA, Roberto Mario

“…Background: Epirubicin (EPX) has been found to be active in hormone-refractory prostate cancer (HRPC) patients. Prolonged EPX infusion has never been…”
Get full text

Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study by Tampellini, Marco, Bitossi, Raffaella, Brizzi, Maria Pia, Saini, Andrea, Tucci, Marcello, Alabiso, Irene, Dogliotti, Luigi

“…The addition of oxaliplatin to the widely employed De Gramont schedule (FOLFOX regimen) in patients with metastatic colorectal cancer improved their outcome…”
Get full text

Effect of vigofac on growth of Gallus gallus fed only a plant diet by BITOSSI, R, SEMPRINI, P

Get more information